PRICE T ROWE ASSOCIATES INC /MD/ - ROCKET PHARMACEUTICALS INC ownership

ROCKET PHARMACEUTICALS INC's ticker is RCKT and the CUSIP is 77313F106. A total of 148 filers reported holding ROCKET PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
PRICE T ROWE ASSOCIATES INC /MD/ ownership history of ROCKET PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$54,053
+28.4%
2,637,951
+24.5%
0.01%
+33.3%
Q2 2023$42,102
+31.6%
2,118,806
+13.5%
0.01%
+20.0%
Q1 2023$31,982
-13.4%
1,866,982
-1.0%
0.01%
-16.7%
Q4 2022$36,914
-99.9%
1,886,290
+15.0%
0.01%
+50.0%
Q3 2022$26,169,000
+35.1%
1,639,643
+16.5%
0.00%
+100.0%
Q2 2022$19,365,000
-51.2%
1,407,349
-43.8%
0.00%
-50.0%
Q1 2022$39,688,000
-17.1%
2,502,386
+14.1%
0.00%0.0%
Q4 2021$47,871,000
-44.5%
2,192,894
-24.0%
0.00%
-50.0%
Q3 2021$86,215,000
-41.9%
2,884,426
-14.0%
0.01%
-42.9%
Q2 2021$148,490,000
-7.0%
3,352,685
-6.8%
0.01%
-12.5%
Q1 2021$159,680,000
-16.3%
3,598,835
+3.4%
0.02%
-20.0%
Q4 2020$190,806,000
+253.8%
3,479,321
+47.5%
0.02%
+233.3%
Q3 2020$53,933,000
+82.8%
2,359,266
+67.3%
0.01%
+50.0%
Q2 2020$29,510,000
+38.5%
1,409,947
-7.7%
0.00%
+33.3%
Q1 2020$21,312,000
-49.5%
1,527,758
-17.6%
0.00%
-40.0%
Q4 2019$42,190,000
+155.6%
1,853,670
+30.8%
0.01%
+150.0%
Q3 2019$16,507,000
-6.2%
1,416,945
+20.8%
0.00%0.0%
Q2 2019$17,594,000
+6.7%
1,172,946
+24.7%
0.00%0.0%
Q1 2019$16,495,000
+22.7%
940,404
+3.7%
0.00%0.0%
Q4 2018$13,441,000
+19.2%
906,959
+98.1%
0.00%0.0%
Q3 2018$11,272,000
+22.9%
457,841
-2.0%
0.00%
+100.0%
Q2 2018$9,170,000
+0.8%
467,120
-3.7%
0.00%0.0%
Q1 2018$9,094,000485,0050.00%
Other shareholders
ROCKET PHARMACEUTICALS INC shareholders Q4 2021
NameSharesValueWeighting ↓
RTW INVESTMENTS, LP 16,037,486$280,250,00019.13%
TANG CAPITAL MANAGEMENT LLC 2,965,485$52,015,0009.58%
Boxer Capital, LLC 1,466,051$25,715,0002.97%
Ghost Tree Capital, LLC 600,000$10,524,0002.75%
BRIDGER MANAGEMENT, LLC 1,529,032$26,819,0002.12%
Cormorant Asset Management, LP 1,700,000$29,818,0002.02%
EcoR1 Capital, LLC 450,000$7,893,0000.73%
UNIVERSITY OF NOTRE DAME DU LAC 171,015$3,000,0000.67%
Virtus ETF Advisers LLC 17,799$312,0000.66%
SPHERA FUNDS MANAGEMENT LTD. 290,001$5,087,0000.46%
View complete list of ROCKET PHARMACEUTICALS INC shareholders